User profiles for "author:Y Liu"

YJ liu

- Verified email at sanofi.com - Cited by 105462

Yayuan Liu

- Verified email at jhu.edu - Cited by 30214

Yunlong Liu

- Verified email at iu.edu - Cited by 16698

Technology roadmap for flexible sensors

…, DJ Lipomi, J Liu, K Liu, N Liu, R Liu, Y Liu, Y Liu…�- ACS�…, 2023 - ACS Publications
Humans rely increasingly on sensors to address grand challenges and to improve quality of
life in the era of digitalization and big data. For ubiquitous sensing, flexible sensors are�…

Reviving the lithium metal anode for high-energy batteries

D Lin, Y Liu, Y Cui�- Nature nanotechnology, 2017 - nature.com
Lithium-ion batteries have had a profound impact on our daily life, but inherent limitations
make it difficult for Li-ion chemistries to meet the growing demands for portable electronics�…

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

YJ Liu�- Annu. Rev. Immunol., 2005 - annualreviews.org
▪ Abstract Type 1 interferon-(α, β, ω)-producing cells (IPCs), also known as plasmacytoid
dendritic cell precursors (pDCs), represent 0.2%–0.8% of peripheral blood mononuclear�…

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Y Liu, Y Yang, C Zhang, F Huang, F Wang…�- Science China Life�…, 2020 - Springer
The outbreak of the 2019-nCoV infection began in December 2019 in Wuhan, Hubei
province, and rapidly spread to many provinces in China as well as other countries. Here we�…

miR2Disease: a manually curated database for microRNA deregulation in human disease

…, M Teng, X Zhang, M Li, G Wang, Y Liu�- Nucleic acids�…, 2009 - academic.oup.com
Abstract 'miR2Disease', a manually curated database, aims at providing a comprehensive
resource of microRNA deregulation in various human diseases. The current version of�…

Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study

YY Liu, Y Wang, TR Walsh, LX Yi, R Zhang…�- The Lancet infectious�…, 2016 - thelancet.com
Background Until now, polymyxin resistance has involved chromosomal mutations but has
never been reported via horizontal gene transfer. During a routine surveillance project on�…

Treatment of 5 critically ill patients with COVID-19 with convalescent plasma

…, F Chen, K Huang, Y Jiang, D Liu, Z Zhang, Y Liu…�- Jama, 2020 - jamanetwork.com
Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific
therapeutic agents and substantial mortality. It is critical to find new treatments. Objective To�…

[HTML][HTML] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

F Zhou, T Yu, R Du, G Fan, Y Liu, Z Liu, J Xiang…�- The lancet, 2020 - thelancet.com
Summary Background Since December, 2019, Wuhan, China, has experienced an outbreak
of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome�…

Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study

LL Ren, YM Wang, ZQ Wu, ZC Xiang, L Guo…�- Chinese medical�…, 2020 - mednexus.org
Background: Human infections with zoonotic coronaviruses (CoVs), including severe acute
respiratory syndrome (SARS)-CoV and Middle East respiratory syndrome (MERS)-CoV�…

Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak

…, Y Peng, S Ge, B Zhen, T Yu, L Wang, H Wang, Y Liu…�- Cancer discovery, 2020 - AACR
The novel COVID-19 outbreak has affected more than 200 countries and territories as of
March 2020. Given that patients with cancer are generally more vulnerable to infections�…